The Phase III trial of AXS-12 showed results over placebo as the company looks towards a new drug application for its ...

Amgen reported 20% weight loss in its MariTide Phase II study results, but a 10% drop in share price suggests investors had ...

MSD has reported that the Phase III ZENITH trial of WINREVAIR for pulmonary arterial hypertension met its primary endpoint.

AstraZeneca has reported positive results from a Phase III trial that evaluated Truqap combined with abiraterone and ADT for ...

The company’s oral, microbiome-changing therapy was well tolerated in patients with amyotrophic lateral sclerosis.

The dispensing of opioid agonists is often restricted to specialised treatment programmes. Credit: Your Hand Please via ...

ArkBio has concluded enrolment and dosing for a Phase I trial of AK0610, to prevent RSV infection, particularly in vulnerable ...

Following the ReThink study failure, Cassava Sciences is discontinuing the Phase III ReFocus trial and open-label study.

The biopharmaceutical industry is being called to take its sustainability efforts to the next level. A new report sheds light ...

Cybersecurity is another critical issue, as health data is particularly vulnerable to breaches, which can lead to identity ...

The Global Coalition for Adaptive Research (GCAR) has executed an agreement to evaluate AstraZeneca's AZD1390 in the GBM ...

SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous HBV)-specific TCR-T therapy, ...